Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare FINGOLIMOD (Fingolimod) and Ozanimod (Zeposia) — clinical data, side effects, and patient experiences.
Fingolimod, Gilenya · Other
How it works
12.1 Mechanism of Action Fingolimod is metabolized by sphingosine kinase to the active metabolite, fingolimod-phosphate. Fingolimod-phosphate is a sphingosine 1-phosphate receptor ...
Approved for
Zeposia · S1P Receptor Modulator
How it works
S1P receptor 1,5 modulator that reduces circulating lymphocytes by retaining them in lymph nodes.
Approved for
Estimated frequency (%) based on clinical trial data
No specific warnings
No head-to-head clinical studies found for FINGOLIMOD vs Ozanimod.
FINGOLIMOD is a Other, while Ozanimod belongs to the S1P Receptor Modulator class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
FINGOLIMOD carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.